Physician profile

James C Miller

Neurological Surgery · Indianapolis, IN

NPI 1083884696

$2,930.43

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$2,216.32
Food and Beverage$679.11
Education$20.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Alphatec Spine, INC $2,404.62 2023 Other - Miscellaneous
Icotec Medical INC. $245.00 2024 Icotec Blackarmor Spine System
Medtronic, INC. $180.81 2021-2024 Unid_pass, Plasmablade(Tm), Atlantis Anterior Cervical Plate System
Stryker Corporation $65.67 2023 N/A
Csl Behring $20.00 2024 Kcentra
Carlsmed, INC. $14.33 2024 Aprevo

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James C Miller

$2,930.43

in general payments reported 2019-2025

Years
2021-2024
Top company
Alphatec Spine, INC

https://glasscript.com/doctor/3544/james-c-miller

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.